National Heart, Lung, and Blood Institute

From WikiMD.org
Jump to navigation Jump to search

National Heart, Lung, and Blood Institute (NHLBI) is a part of the National Institutes of Health (NIH), located in Bethesda, Maryland, United States. The NHLBI provides global leadership for research, training, and education programs to promote the prevention and treatment of heart, lung, and blood diseases.

Pronunciation

The National Heart, Lung, and Blood Institute is pronounced as /ˈnæʃənəl hɑːrt, lʌŋ, ænd blʌd ˈɪnstɪtjuːt/.

Etymology

The term "National Heart, Lung, and Blood Institute" is derived from its function. It is a national institute in the United States that focuses on the research and treatment of heart, lung, and blood diseases.

Related Terms

  • Heart disease: A range of conditions that affect your heart. Diseases under the heart disease umbrella include blood vessel diseases, such as coronary artery disease; heart rhythm problems (arrhythmias); and heart defects you're born with (congenital heart defects), among others.
  • Lung disease: Any problem in the lungs that prevents the lungs from working properly. There are three main types of lung disease: Airway diseases, Lung tissue diseases, and Lung circulation diseases.
  • Blood disease: Diseases that affect the blood, such as anemia, leukemia, lymphoma, multiple myeloma, and myelodysplastic syndromes.
  • National Institutes of Health: The primary agency of the United States government responsible for biomedical and public health research.

See Also

External links

Esculaap.svg

This WikiMD article is a stub. You can help make it a full article.

Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski

Retrieved from "https://wikimd.org/w/index.php?title=National_Heart,_Lung,_and_Blood_Institute&oldid=1538673"